Target intelligence / Profile preview

Protein-protein interaction domain

Molecular classification
Other (modular domain, not a protein, enzyme, or receptor), Sometimes classified by subtypes: SH2 domain, SH3 domain, PDZ domain, WW domain, SAM domain, FERM domain, Calponin homology (CH) domain, Pleckstrin homology domain, etc.
01

Overview

Protein-protein interaction domains are modular regions, typically 35–150 amino acids in length, within proteins that enable them to bind specifically to other proteins or protein motifs through recognition of short linear or post-translationally modified sequences (such as phosphotyrosine for SH2 domains or proline-rich motifs for SH3 domains)[2][7]. These domains serve as “plug-and-play” elements in multidomain proteins, controlling the assembly of signal transduction complexes, cytoskeletal dynamics, protein localization, and the integration of complex cellular responses[2][6][7]. Each domain type recognizes a consensus sequence or structural motif, and their ability to form transient, regulated interactions is crucial for nearly all aspects of cell biology and disease. While they are not themselves drug targets in the sense of a canonical receptor or enzyme, individual protein-protein interaction domains (such as SH2, SH3, or PDZ domains) within specific proteins can serve as the focus of therapeutic intervention in diseases like cancer or viral infection, via the disruption of critical protein interactions[5][7].

Other names
Protein interaction domainsPIDsinteraction domains
02

Mechanism of action

Inhibition or stabilization of specific protein-protein interactions through direct binding to interaction domains (e.g., blocking SH2 or SH3 domain recognition) Modulation of signaling complexes via disruption or stabilization of domain-peptide or domain-domain interactions

03

Biological functions

Signal transductionAssembly of protein complexesTargeting of proteins to subcellular locationsEnzyme regulation (allosteric effects)Substrate channelingProtein localizationRegulation of post-translational modificationsCell cycle controlApoptosisImmune responseCytoskeletal organization
04

Disease associations

CancerViral infectionNeurodegenerative diseaseOther diseases linked to dysregulated protein-protein interactions
05

Safety considerations

Targeting protein-protein interaction domains poses risks due to the potential for off-target effects on essential cellular pathways and the challenge of specificityMany such domains are present in multiple proteins, making selective modulation difficult and raising the possibility of widespread cellular effects
06

Interacting drugs

Peptides and small molecules targeting specific protein-protein interaction domains (examples include SH2 or PDZ domain inhibitors used as tool compounds in research; no broadly approved drugs)
07

Biomarkers

None broadly established; some domains are used as biomarkers in research for pathway activation (e.g., phosphorylated tyrosine recognized by SH2 domains as surrogate markers for kinase activation)

Beyond the preview

Go deeper on Protein-protein interaction domain.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein-protein interaction domain.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call